These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11716917)

  • 1. Effect of infliximab on threatening panuveitis in Behçet's disease.
    Muñoz-Fernández S; Hidalgo V; Fernández-Melón J; Schlincker A; Martín-Mola E
    Lancet; 2001 Nov; 358(9293):1644. PubMed ID: 11716917
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of infliximab on sight-threatening panuveitis in Behçet's disease.
    Sfikakis PP; Theodossiadis PG; Katsiari CG; Kaklamanis P; Markomichelakis NN
    Lancet; 2001 Jul; 358(9278):295-6. PubMed ID: 11498218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infliximab in refractory uveitis due to Behçet's disease.
    Wechsler B; Sablé-Fourtassou R; Bodaghi B; Huong DL; Cassoux N; Badelon I; Fain O; LeHoang P; Piette JC
    Clin Exp Rheumatol; 2004; 22(4 Suppl 34):S14-6. PubMed ID: 15515776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful long-term treatment of refractory Adamantiades-Behçet's disease (ABD) with infliximab: report of two patients.
    Katsiari CG; Theodossiadis PG; Kaklamanis PG; Markomichelakis NN; Sfikakis PP
    Adv Exp Med Biol; 2003; 528():551-5. PubMed ID: 12918762
    [No Abstract]   [Full Text] [Related]  

  • 5. Reconstitution of disrupted photoreceptor layer in uveitis associated with Behçet's disease by infliximab treatment.
    Takeuchi M; Harimoto K; Taguchi M; Sakurai Y
    BMC Ophthalmol; 2015 Dec; 15():177. PubMed ID: 26653575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the literature.
    Pipitone N; Olivieri I; Padula A; D'angelo S; Nigro A; Zuccoli G; Boiardi L; Salvarani C
    Arthritis Rheum; 2008 Feb; 59(2):285-90. PubMed ID: 18240181
    [No Abstract]   [Full Text] [Related]  

  • 7. The efficacy of a single dose of infliximab in the treatment of Behçet's disease uveitis.
    Arayssi T; Hamra R; Homeidan F; Uthman I; Awwad ST; Mroue K; Mansour W; Bashshur ZF
    Clin Exp Rheumatol; 2005; 23(3):427. PubMed ID: 15971438
    [No Abstract]   [Full Text] [Related]  

  • 8. Infliximab in the treatment of hepatic vein thrombosis (Budd-Chiari syndrome) in three patients with Behcet's syndrome.
    Seyahi E; Hamuryudan V; Hatemi G; Melikoglu M; Celik S; Fresko I; Yurdakul S; Yazici H
    Rheumatology (Oxford); 2007 Jul; 46(7):1213-4. PubMed ID: 17478465
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment of life-threatening intestinal ulcer in Behçet's disease with infliximab: rapid healing of Behçet's ulcer with infliximab.
    Ju JH; Kwok SK; Seo SH; Yoon CH; Kim HY; Park SH
    Clin Rheumatol; 2007 Aug; 26(8):1383-5. PubMed ID: 17039261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of severe Behçet's disease with anti-TNF-alpha: infliximab. A case report].
    Andreu M; Ramanoelina J; Fajnkuchen F; Mouthon L; Cohen P; Laroche L; Guillevin L
    Ann Med Interne (Paris); 2002 Oct; 153(6):414-5. PubMed ID: 12486393
    [No Abstract]   [Full Text] [Related]  

  • 11. Remission of Behçet's syndrome with TNFalpha blocking treatment.
    Rozenbaum M; Rosner I; Portnoy E
    Ann Rheum Dis; 2002 Mar; 61(3):283-4. PubMed ID: 11830448
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of infliximab on refractory uveitis in Behcet's disease.
    Sayarlioglu M; Cinal A; Topcu N; Demirok A
    Ann Pharmacother; 2004 May; 38(5):901-2. PubMed ID: 15010522
    [No Abstract]   [Full Text] [Related]  

  • 13. Behçet's disease: visual acuity after 5 years in patients with alpha-interferon treatment.
    Deuter CM; Kötter I; Günaydin I; Zierhut M; Stübiger N
    Adv Exp Med Biol; 2003; 528():525-8. PubMed ID: 12918756
    [No Abstract]   [Full Text] [Related]  

  • 14. Switching to adalimumab is effective in a case of neuro-Behcet's disease refractory to infliximab.
    Leccese P; D'Angelo S; Angela P; Coniglio G; Olivieri I
    Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S102. PubMed ID: 20868587
    [No Abstract]   [Full Text] [Related]  

  • 15. [Spondylarthropathy with Behçet's disease: response to infliximab].
    Toussirot E; Schwartz C; Hafsaoui C; Bossert M; Bertolini E; Wendling D
    Presse Med; 2009; 38(7-8):1183-5. PubMed ID: 19395229
    [No Abstract]   [Full Text] [Related]  

  • 16. Infliximab for the treatment of posterior uveitis with retinal neovascularization in Behçet disease.
    Giansanti F; Barbera ML; Virgili G; Pieri B; Emmi L; Menchini U
    Eur J Ophthalmol; 2004; 14(5):445-8. PubMed ID: 15506610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of genital ulcers with infliximab in Behcet's disease.
    Haugeberg G; Velken M; Johnsen V
    Ann Rheum Dis; 2004 Jun; 63(6):744-5. PubMed ID: 15140785
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behçet's disease.
    Triolo G; Vadalà M; Accardo-Palumbo A; Ferrante A; Ciccia F; Giardina E; Citarrella P; Lodato G; Licata G
    Ann Rheum Dis; 2002 Jun; 61(6):560-1. PubMed ID: 12006336
    [No Abstract]   [Full Text] [Related]  

  • 19. Infliximab treatment for severe orogenital ulceration in Behçet's disease.
    Connolly M; Armstrong JS; Buckley DA
    Br J Dermatol; 2005 Nov; 153(5):1073-5. PubMed ID: 16225632
    [No Abstract]   [Full Text] [Related]  

  • 20. Infliximab monotherapy versus infliximab and colchicine combination therapy in patients with Behçet's disease.
    Takeuchi M; Asukata Y; Kawagoe T; Ito N; Nishide T; Mizuki N
    Ocul Immunol Inflamm; 2012 Jun; 20(3):193-7. PubMed ID: 22486264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.